Bioventus Inc (BVS)
11.51
+0.10
(+0.88%)
USD |
NASDAQ |
Nov 21, 16:00
11.52
+0.01
(+0.09%)
After-Hours: 20:00
Bioventus Price to Book Value: 5.063 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.014 |
| November 19, 2024 | 5.094 |
| November 18, 2024 | 4.944 |
| November 15, 2024 | 4.940 |
| November 14, 2024 | 4.891 |
| November 13, 2024 | 4.905 |
| November 12, 2024 | 5.204 |
| November 11, 2024 | 5.467 |
| November 08, 2024 | 5.195 |
| November 07, 2024 | 4.940 |
| November 06, 2024 | 4.957 |
| November 05, 2024 | 5.045 |
| November 04, 2024 | 6.025 |
| November 01, 2024 | 5.968 |
| October 31, 2024 | 5.964 |
| October 30, 2024 | 5.968 |
| October 29, 2024 | 5.850 |
| October 28, 2024 | 5.714 |
| October 25, 2024 | 5.780 |
| October 24, 2024 | 5.841 |
| October 23, 2024 | 5.815 |
| October 22, 2024 | 5.675 |
| October 21, 2024 | 5.574 |
| October 18, 2024 | 5.666 |
| October 17, 2024 | 5.491 |
| Date | Value |
|---|---|
| October 16, 2024 | 5.653 |
| October 15, 2024 | 5.570 |
| October 14, 2024 | 5.500 |
| October 11, 2024 | 5.307 |
| October 10, 2024 | 4.922 |
| October 09, 2024 | 5.018 |
| October 08, 2024 | 5.071 |
| October 07, 2024 | 4.896 |
| October 04, 2024 | 5.141 |
| October 03, 2024 | 5.106 |
| October 02, 2024 | 5.154 |
| October 01, 2024 | 5.158 |
| September 30, 2024 | 5.228 |
| September 27, 2024 | 5.027 |
| September 26, 2024 | 4.772 |
| September 25, 2024 | 5.018 |
| September 24, 2024 | 4.941 |
| September 23, 2024 | 4.906 |
| September 20, 2024 | 5.118 |
| September 19, 2024 | 5.006 |
| September 18, 2024 | 5.049 |
| September 17, 2024 | 4.911 |
| September 16, 2024 | 4.777 |
| September 13, 2024 | 4.824 |
| September 12, 2024 | 4.712 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2317
Minimum
Mar 29 2023
6.536
Maximum
Nov 03 2021
2.366
Average
1.727
Median
Price to Book Value Benchmarks
| Boston Scientific Corp | 6.512 |
| Insulet Corp | 16.44 |
| Perspective Therapeutics Inc | 0.6153 |
| Xtant Medical Holdings Inc | 1.249 |
| Catheter Precision Inc | 0.2596 |
Price to Book Value Related Metrics
| PS Ratio | 1.327 |
| Price to Free Cash Flow | 25.36 |
| Price | 11.51 |
| Earnings Yield | -5.21% |
| Market Cap | 753.04M |
| Operating PE Ratio | 41.88 |